Which has better earnings & valuation, SIBN or QTRX?

SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SiBone $200.93M 4.28 -$18.90M -$0.34 N/A Quanterix $138.90M 1.12 -$107.15M -$2.63 N/A

Is SIBN or QTRX more profitable?

SiBone has a net margin of -6.85% compared to Quanterix's net margin of -80.25%. SiBone's return on equity of -8.23% beat Quanterix's return on equity. Company Net Margins Return on Equity Return on Assets SiBone -6.85% -8.23% -6.07% Quanterix -80.25% -26.09% -19.03%

Does the media refer more to SIBN or QTRX?

In the previous week, SiBone had 10 more articles in the media than Quanterix. MarketBeat recorded 13 mentions for SiBone and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat SiBone's score of 0.35 indicating that Quanterix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quanterix 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, QTRX or OABI?

OmniAb has lower revenue, but higher earnings than Quanterix. OmniAb is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quanterix $138.90M 1.12 -$107.15M -$2.63 N/A OmniAb $38.46M 18.03 -$64.78M -$0.36 N/A

Is QTRX or OABI more profitable?

Quanterix has a net margin of -80.25% compared to OmniAb's net margin of -115.12%. OmniAb's return on equity of -16.59% beat Quanterix's return on equity. Company Net Margins Return on Equity Return on Assets Quanterix -80.25% -26.09% -19.03% OmniAb -115.12% -16.59% -14.82%

Does the media favor QTRX or OABI?

In the previous week, OmniAb had 7 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for OmniAb and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat OmniAb's score of 0.53 indicating that Quanterix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quanterix 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OmniAb 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, QTRX or EVO?

Quanterix has higher earnings, but lower revenue than Evotec. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quanterix $138.90M 1.12 -$107.15M -$2.63 N/A Evotec $891.97M 0.61 -$117.12M N/A N/A

Is QTRX or EVO more profitable?

Evotec has a net margin of -26.20% compared to Quanterix's net margin of -80.25%. Evotec's return on equity of -24.93% beat Quanterix's return on equity. Company Net Margins Return on Equity Return on Assets Quanterix -80.25% -26.09% -19.03% Evotec -26.20% -24.93% -11.35%

Does the media favor QTRX or EVO?

In the previous week, Evotec had 1 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for Evotec and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat Evotec's score of 0.01 indicating that Quanterix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quanterix 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evotec 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is TKNO or QTRX more profitable?

Alpha Teknova has a net margin of -38.37% compared to Quanterix's net margin of -80.25%. Alpha Teknova's return on equity of -24.94% beat Quanterix's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -38.37% -24.94% -16.53% Quanterix -80.25% -26.09% -19.03%

Does the media favor TKNO or QTRX?

In the previous week, Alpha Teknova had 1 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for Alpha Teknova and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat Alpha Teknova's score of 0.43 indicating that Quanterix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quanterix 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer QTRX or SLP?

In the previous week, Simulations Plus had 8 more articles in the media than Quanterix. MarketBeat recorded 11 mentions for Simulations Plus and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat Simulations Plus' score of 0.50 indicating that Quanterix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quanterix 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Simulations Plus 1 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Quanterix (QTRX) Competitors

$3.28 +0.07 (+2.18%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$3.28 0.00 (0.00%)

As of 10/9/2026 07:54 PM Eastern

Compare

QTRX vs. SIBN, OABI, EVO, TKNO, and SLP

Should you buy Quanterix stock or one of its competitors? Quanterix's main competitors and comparable companies include SiBone (SIBN), OmniAb (OABI), Evotec (EVO), Alpha Teknova (TKNO), and Simulations Plus (SLP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Quanterix compare to SiBone?

SiBone (NASDAQ:SIBN) and Quanterix (NASDAQ:QTRX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

In the previous week, SiBone had 10 more articles in the media than Quanterix. MarketBeat recorded 13 mentions for SiBone and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat SiBone's score of 0.35 indicating that Quanterix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SiBone	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quanterix	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SiBone has a net margin of -6.85% compared to Quanterix's net margin of -80.25%. SiBone's return on equity of -8.23% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiBone	-6.85%	-8.23%	-6.07%
Quanterix	-80.25%	-26.09%	-19.03%

98.1% of SiBone shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 4.0% of SiBone shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SiBone presently has a consensus price target of $24.17, suggesting a potential upside of 24.76%. Quanterix has a consensus price target of $3.00, suggesting a potential downside of 8.54%. Given SiBone's stronger consensus rating and higher possible upside, research analysts plainly believe SiBone is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiBone	$200.93M	4.28	-$18.90M	-$0.34	N/A
Quanterix	$138.90M	1.12	-$107.15M	-$2.63	N/A

SiBone has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Quanterix has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market.

Summary

SiBone beats Quanterix on 13 of the 16 factors compared between the two stocks.

How does Quanterix compare to OmniAb?

Quanterix (NASDAQ:QTRX) and OmniAb (NASDAQ:OABI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

86.5% of Quanterix shares are held by institutional investors. Comparatively, 72.1% of OmniAb shares are held by institutional investors. 1.5% of Quanterix shares are held by company insiders. Comparatively, 9.8% of OmniAb shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OmniAb has lower revenue, but higher earnings than Quanterix. OmniAb is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quanterix	$138.90M	1.12	-$107.15M	-$2.63	N/A
OmniAb	$38.46M	18.03	-$64.78M	-$0.36	N/A

Quanterix presently has a consensus target price of $3.00, suggesting a potential downside of 8.54%. OmniAb has a consensus target price of $11.50, suggesting a potential upside of 140.08%. Given OmniAb's stronger consensus rating and higher possible upside, analysts clearly believe OmniAb is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
OmniAb	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, OmniAb had 7 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for OmniAb and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat OmniAb's score of 0.53 indicating that Quanterix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quanterix	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OmniAb	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Quanterix has a net margin of -80.25% compared to OmniAb's net margin of -115.12%. OmniAb's return on equity of -16.59% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quanterix	-80.25%	-26.09%	-19.03%
OmniAb	-115.12%	-16.59%	-14.82%

Quanterix has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market. Comparatively, OmniAb has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

Summary

OmniAb beats Quanterix on 10 of the 16 factors compared between the two stocks.

How does Quanterix compare to Evotec?

Quanterix (NASDAQ:QTRX) and Evotec (NASDAQ:EVO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

Quanterix has higher earnings, but lower revenue than Evotec.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quanterix	$138.90M	1.12	-$107.15M	-$2.63	N/A
Evotec	$891.97M	0.61	-$117.12M	N/A	N/A

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 5.8% of Evotec shares are owned by institutional investors. 1.5% of Quanterix shares are owned by company insiders. Comparatively, 1.0% of Evotec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Quanterix currently has a consensus target price of $3.00, indicating a potential downside of 8.54%. Evotec has a consensus target price of $3.00, indicating a potential upside of 96.08%. Given Evotec's stronger consensus rating and higher possible upside, analysts plainly believe Evotec is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Evotec	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Quanterix has a beta of 1.02, meaning that its share price is 2% more volatile than the broader market. Comparatively, Evotec has a beta of 1.97, meaning that its share price is 97% more volatile than the broader market.

In the previous week, Evotec had 1 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for Evotec and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat Evotec's score of 0.01 indicating that Quanterix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quanterix	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evotec	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Evotec has a net margin of -26.20% compared to Quanterix's net margin of -80.25%. Evotec's return on equity of -24.93% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quanterix	-80.25%	-26.09%	-19.03%
Evotec	-26.20%	-24.93%	-11.35%

Summary

Evotec beats Quanterix on 9 of the 14 factors compared between the two stocks.

How does Quanterix compare to Alpha Teknova?

Alpha Teknova (NASDAQ:TKNO) and Quanterix (NASDAQ:QTRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Alpha Teknova has higher earnings, but lower revenue than Quanterix. Alpha Teknova is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	11.70	-$17.26M	-$0.31	N/A
Quanterix	$138.90M	1.12	-$107.15M	-$2.63	N/A

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 13.2% of Alpha Teknova shares are held by company insiders. Comparatively, 1.5% of Quanterix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Alpha Teknova currently has a consensus price target of $8.00, suggesting a potential downside of 9.50%. Quanterix has a consensus price target of $3.00, suggesting a potential downside of 8.54%. Given Quanterix's higher possible upside, analysts plainly believe Quanterix is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Alpha Teknova had 1 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for Alpha Teknova and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat Alpha Teknova's score of 0.43 indicating that Quanterix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quanterix	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Teknova has a net margin of -38.37% compared to Quanterix's net margin of -80.25%. Alpha Teknova's return on equity of -24.94% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
Quanterix	-80.25%	-26.09%	-19.03%

Alpha Teknova has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, Quanterix has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market.

Summary

Alpha Teknova beats Quanterix on 10 of the 16 factors compared between the two stocks.

How does Quanterix compare to Simulations Plus?

Quanterix (NASDAQ:QTRX) and Simulations Plus (NASDAQ:SLP) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Quanterix has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, Simulations Plus has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market.

86.5% of Quanterix shares are held by institutional investors. Comparatively, 78.1% of Simulations Plus shares are held by institutional investors. 1.5% of Quanterix shares are held by insiders. Comparatively, 19.1% of Simulations Plus shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Quanterix currently has a consensus price target of $3.00, suggesting a potential downside of 8.54%. Simulations Plus has a consensus price target of $17.25, suggesting a potential downside of 6.76%. Given Simulations Plus' stronger consensus rating and higher possible upside, analysts clearly believe Simulations Plus is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Simulations Plus	1 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.88

In the previous week, Simulations Plus had 8 more articles in the media than Quanterix. MarketBeat recorded 11 mentions for Simulations Plus and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.86 beat Simulations Plus' score of 0.50 indicating that Quanterix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quanterix	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Simulations Plus	1 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Simulations Plus has lower revenue, but higher earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quanterix	$138.90M	1.12	-$107.15M	-$2.63	N/A
Simulations Plus	$82.06M	4.56	-$64.72M	$0.40	46.25

Simulations Plus has a net margin of 9.88% compared to Quanterix's net margin of -80.25%. Simulations Plus' return on equity of 13.50% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quanterix	-80.25%	-26.09%	-19.03%
Simulations Plus	9.88%	13.50%	12.45%

Summary

Simulations Plus beats Quanterix on 12 of the 15 factors compared between the two stocks.

Get Quanterix News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTRX vs. The Competition

Export

Metric	Quanterix	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$151.81M	$10.43B	$7.16B	$13.21B
Dividend Yield	N/A	1.45%	2.53%	16.37%
P/E Ratio	-1.25	32.42	275.30	26.16
Price / Sales	1.12	106.67	635.97	107.50
Price / Cash	N/A	27.23	76.38	53.09
Price / Book	0.52	6.48	11.22	6.33
Net Income	-$107.15M	$56.67B	$3.50B	$382.15M
7 Day Performance	-9.89%	-1.01%	-0.89%	-1.40%
1 Month Performance	31.20%	8.89%	-4.42%	-3.47%
1 Year Performance	-41.84%	32.14%	7.03%	1.18%

Quanterix Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTRX Quanterix	1.096 of 5 stars	$3.28 +2.2%	$3.00 -8.5%	-45.2%	$151.81M	$138.90M	N/A	450	Positive News
SIBN SiBone	3.3933 of 5 stars	$19.74 -0.4%	$24.17 +22.4%	+23.2%	$877.76M	$213.60M	N/A	376	News Coverage Gap Down
OABI OmniAb	2.4069 of 5 stars	$4.96 +0.9%	$11.00 +121.6%	+163.2%	$712.32M	$18.67M	N/A	89	Analyst Forecast
EVO Evotec	3.3829 of 5 stars	$1.71 +3.3%	$3.00 +75.0%	-61.2%	$610.23M	$717.28M	N/A	4,553	Short Interest Decrease
TKNO Alpha Teknova	1.4214 of 5 stars	$9.33 +3.7%	$8.00 -14.3%	+75.0%	$488.66M	$40.52M	N/A	158

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTRX) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quanterix (QTRX) Competitors